Verified Clinical Trials (VCT) will be attending SCOPE Summit 2026, where leaders from across the industry convene to advance the future of Clinical Trials.
At SCOPE, our team will be reconnecting with many of our long-standing clients, colleagues, and friends, while also meeting new sponsors, CROs, and research partners. These conversations are essential as the industry continues to address challenges that directly affect trial outcomes.
A central theme of our discussions will be how Verified Clinical Trials helps prevent duplicate subjects in clinical trials and professional research subjects from entering Clinical Trials. These risks can compromise research subject safety, distort datasets, and threaten study validity if left unaddressed.
By detecting and preventing duplicate and professional research subjects at screening—and maintaining protections throughout study participation—Verified Clinical Trials strengthens data quality, enhances research subject safety, and helps sponsors and CROs improve the quality and integrity of clinical research globally.
We look forward to meaningful discussions at SCOPE Summit 2026 and to continued collaboration with industry partners committed to safer, more reliable clinical research worldwide.